Advertisement

Natural Immunity to Endogenous Oncornaviruses in Mice

  • James N. Ihle
  • M. G. HannaJr.
Part of the Contemporary Topics in Immunobiology book series (CTI, volume 6)

Abstract

Murine C-type viruses have been etiologically linked to spontaneous leukemias in mice (Gross, 1951). These viruses are endogenous in mice and are vertically transmitted (Huebner and Todaro, 1969; Rowe et al., 1971; Aaronson et al., 1971). A number of biologically distinguishable C-type viruses occur naturally in various strains of mice. Ecotropic viruses, which include the AKR or Gross-type viruses, are capable of replicating in mouse cells. These viruses have been further differentiated by their preference for replication in various mouse cells into N- or B-tropic viruses (Pincus et al., 1971), although by hybridization experiments the N and B viruses are closely related (Callahan et al., 1974). Xenotropic viruses are characterized by their ability to replicate in cells of other species (Levy, 1973). Two groups of xenotropic viruses have been identified by serological techniques (Stephenson et al., 1974) and by hybridization experiments (Callahan et al., 1975). The xenotropic viruses are only partially related to the ecotropic viruses, as determined by hybridization (Callahan et al., 1974), and to date have not been implicated in any spontaneous neoplasia of mice.

Keywords

Murine Leukemia Virus Natural Antibody African Swine Fever Virus Expression Immune Seron 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aaronson, S. A., and Stephenson, J. R., 1974, Widespread natural occurrence of high titered neutralizing antibodies to a specific class of endogenous murine type-C virus, Proc. Natl Acad. Sci. U.S.A. 71: 1957.PubMedCrossRefGoogle Scholar
  2. Aaronson, S. A., Todaro, G. J., and E. M. Scolnick, 1971, Induction of murine C-type viruses from clonal lines of virus-free BALB/3T3 cells, Science 174: 157.PubMedCrossRefGoogle Scholar
  3. Batzing, B. L., Yurconic, M., Jr., and Hanna, M. G., Jr., 1974, Autogenous immunity to endogenous RNA tumor virus: Chronic humoral immune response to virus envelope antigens in B6C3F1 mice, J. Natl Cancer Inst. 52: 117.PubMedGoogle Scholar
  4. Blank, S. E., Leslie, G. A., and Clem, L. W., 1972, Antibody affinity and valence in viral neutralization, J. Immunol 108: 665.PubMedGoogle Scholar
  5. Breese, S. S., Jr., Stone, S. S., De Boer, C. J., and Hess, W. R., 1967, Electron microscopy of the interaction of African Swine Fever virus with ferritin-conjugated antibody, Virology 31: 508.PubMedCrossRefGoogle Scholar
  6. Callahan, R., Benveniste, R. E., Lieber, M. M., and Todaro, G. J., 1974, Nucleic acid homology of murine type-C viral genes, J. Virol 14: 1394.PubMedGoogle Scholar
  7. Callahan, R., Lieber, M. M., and Todaro, G. J., 1975, Nucleic acid homology of murine xenotropic type-C viruses, J. Virol 15: 1378.PubMedGoogle Scholar
  8. Chattopadhyay, S. K., Rowe, W. P., Teich, N. M., and Lowry, D. R., 1975, Definitive evidence that the murine C-type virus inducing locus AKV-1 is viral genetic material, Proc. Natl Acad. Sci. U.S.A. 72: 906.PubMedCrossRefGoogle Scholar
  9. Clapp, N. K., and Yuhas, J. M., 1973, Suggested correlation between radiation-induced immunosuppression and radiogenic leukemia in mice, J. Natl Cancer Inst. 51: 1211.PubMedGoogle Scholar
  10. De Boer, C. J., Hess, W. R., and Dardiri, A. H., 1969, Studies to determine the presence of neutralizing antibody in sera and kidneys from swine recovered from African swine fever, Arch. Gesamte Virusforsch. 27: 44.CrossRefGoogle Scholar
  11. Gerloff, R. K., Hoyer, B. H., and McLaren, L. C., 1962, Precipitation of radiolabeled polio virus with specific antibody antiglobulins, J. Immunol 89: 559.PubMedGoogle Scholar
  12. Grant, J. P., Bigner, D. D., Fischinger, P. J., and Bolognesi, D. P., 1974, Expression of murine leukemia virus structural antigens on the surface of chemically-induced murine sarcomas, Proc. Natl Acad. Sci. U.S.A. 71: 5037.PubMedCrossRefGoogle Scholar
  13. Gross, L., 1951, Pathogeneic properties and vertical transmission of the mouse leukemia agent, Proc. Soc. Exp. Med. 78: 342.Google Scholar
  14. Hanna, M. G., Jr., Tennant, R. W., Yuhas, J. M., Clapp, N. K., Batzing, B., and Snodgrass, M., 1973, Autogenous immunity to endogenous RNA tumor virus in mice with a low natural incidence of lymphoma, Cancer Res. 32: 2226.Google Scholar
  15. Hanna, M. G., Jr., Ihle, J. N., Batzing, B. L., Tennant, R. W., and Schenley, C. K., 1975, Assessment of reactivities of natural antibodies to endogenous RNA tumor virus envelope antigens and virus-induced cell surface antigens, Cancer Res. 35: 164.PubMedGoogle Scholar
  16. Heffner, R. R., Jr., and Schluderberg, A., 1967, Specificity of the primary and secondary antibody responses to myxoviruses, J. Immunol 99: 668.Google Scholar
  17. Hirsch, M. E., Kelly, A. P., Proffitt, M. R., and Black, P. H., 1975, Cell-mediated immunity to antigens associated with endogenous murine C-type leukemia viruses, Science 187: 959.PubMedCrossRefGoogle Scholar
  18. Hollis, V. W., Jr., Aoki, T., Barrera, O., Oldstone, M. B. A., and Dixon, F. J., 1974, Detection of naturally occurring antibodies to RNA-dependent DNA polymerase of murine leukemia virus in kidney eluates of AKR mice, J. Virol 13: 448.PubMedGoogle Scholar
  19. Huebner, R. J., and Todaro, G. J., 1969, Oncogenes of RNA tumor viruses as determinants of cancer, Proc. Natl Acad. Sci. U.S.A. 64: 1087.PubMedCrossRefGoogle Scholar
  20. Huebner, R. J., Sarma, P. S., Kelloff, G. J., Gliden, R. V., Meier, H., Meyers, D. D., and Peters, R. L., 1971, Immunological tolerance to RNA tumor virus genome expression: Significance of tolerance and prenatal expression in embryogenesis and tumorigenesis, Ann. N. Y. Acad. Sci. 181: 246.CrossRefGoogle Scholar
  21. Ihle, J. N., Yurconic, M., Jr., and Hanna, M. G., Jr., 1973, Autogenous immunity to endogenous RNA tumor virus: Radioimmune precipitation assay of mouse serum antibody levels, J. Exp. Med. 138: 194.PubMedCrossRefGoogle Scholar
  22. Ihle, J. N., Hanna, M. G., Jr., Roberson, L. E., and Kenney, F. T., 1974, Autogenous immunity to endogenous RNA tumor virus: Identification of antibody reactivity to select viral antigens, J. Exp. Med. 136: 1568.CrossRefGoogle Scholar
  23. Ihle, J. N., Denny, T., and Bolognesi, D. P., 1975c, Purification and serological characterization of the major envelope glycoprotein from AKR murine leukemia virus and its reactivity with autogenous immune sera from mice, J. Virol 17: 727.Google Scholar
  24. Ihle, J. N., Hanna, M. G., Jr., Schafer, W., Hunsmann, G., Bolognesi, D. P., and Hiiper, G., 1975, Polypeptides of mammalian oncornaviruses III. Localization of pl5 and reactivity with natural antibody, Virology 63: 60.Google Scholar
  25. Ihle, J. N., Arthur, L. O., and Fine, D. L., 1976a, Autogenous immunity to mouse mammary tumor virus in mouse strains of high and low mammary tumor incidence, Cancer Res. 36: 2840.PubMedGoogle Scholar
  26. Ihle, J. N., Domotor, J. J., Jr., and Bengali, K. M., 1976b, Characterization of the type and group specificities of the immune response in mice to murine leukemia viruses, J. Virol 18: 124.PubMedGoogle Scholar
  27. Ikeda, H., Hardy, W., Jr., Tress, E., and Fleissner, E., 1975, Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. I. Identification of a new murine viral protein, p15(E), J. Virol. 16: 53.PubMedGoogle Scholar
  28. Lee, J. C., and Ihle, J. N., 1975, Autogenous immunity to endogenous RNA tumor virus: Reactivity of natural immune sera to antigenic determinants of several biologically distinct murine leukemia viruses, J. Natl. Cancer Inst. 55: 831.PubMedGoogle Scholar
  29. Lee, J. C., Hanna, M. G., Jr., Ihle, J. N., and Aaronson, S. A., 1974, Autogenous immunity to endogenous RNA tumor virus: Differential reactivities of IgM and IgG to virus envelope antigens, J. Virol 14: 773.PubMedGoogle Scholar
  30. Levy, J. A., 1973, Xenotropic viruses: Murine leukemia viruses associated with NIH Swiss, NZB and other mouse strains, Science 182: 1151.PubMedCrossRefGoogle Scholar
  31. Levy, J. A., Ihle, J. N., Oleszko, O., and Barnes, R. D., 1975, Virus-specific neutralization by a soluble non-immunoglobulin factor found naturally in normal mouse sera, Proc. Natl. Acad. Sci. U.S.A. 72: 5071.PubMedCrossRefGoogle Scholar
  32. Lilly, F., 1966, The inheritance of susceptibility to the Gross leukemia virus in mice, Genetics 53: 529.PubMedGoogle Scholar
  33. Lilly, F., 1972, Mouse leukemia: A model of a multiple-gene disease, J. Natl. Cancer Inst. 49: 927.PubMedGoogle Scholar
  34. Lilly, F., and Pincus, T., 1973, Genetic control of murine viral leukemogenesis advances, Cancer Res. 17: 231.CrossRefGoogle Scholar
  35. Lilly, F., Duran-Reynals, M. L., and Rowe, W. P., 1975, Correlation of early murine leukemia virus titer and H-2 type with spontaneous leukemia in mice of the BALB/c X AKR cross: A genetic analysis, J. Exp. Med. 141: 882.PubMedGoogle Scholar
  36. Martin, S. E., and Martin, W. J., 1975, Naturally occurring cytotoxic tumor reactive antibodies directed against type C viral envelope antigens, Nature (London) 256: 498.CrossRefGoogle Scholar
  37. Meier, H., Taylor, B. A., Cherry, M., and Huebner, R. T., 1973, Host-gene control of type-C RNA tumor virus expression and tumorigenesis in inbred mice, Proc. Natl. Acad. Sci. U.S.A. 70: 1450.PubMedCrossRefGoogle Scholar
  38. Mellors, R. C., Aoki, T., and Huebner, R. J., 1969, Further implications of murine leukemia-like virus in the disorders of NZB mice, J. Exp. Med. 129: 1045.PubMedCrossRefGoogle Scholar
  39. Mellors, R. C., Shirai, T., Aoki, T., Huebner, R. J., and Krawczynski, K., 1971, Wild-type Gross leukemia virus and the pathogenesis of the glomerulonephritis of New Zealand mice, J. Exp. Med. 133: 113.PubMedCrossRefGoogle Scholar
  40. Nowinski, R. C., and Kaehler, S. L., 1974, Antibody to leukemia virus: Widespread occurrence in inbred mice, Science 185: 869.PubMedCrossRefGoogle Scholar
  41. Nowinski, R. C., and Klein, P. A., 1975, Anomalous reactions of mouse allo antisera with cultured tumor cells. II. Cytotoxicity is caused by antibodies to leukemia viruses, J. Immunol. 115: 1261.PubMedGoogle Scholar
  42. Nowinski, R. C., Fleissner, E., Sarkar, N. H., and Aoki, T., 1972, Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. II. Mammalian leukemia-sarcoma viruses, J. Virol. 9: 354.Google Scholar
  43. Old, L. J., Boyse, E. A., Oettgen, H. F., 1968. Serologic approaches to the study of cancer in animals and man, Cancer Res. 28: 1288.PubMedGoogle Scholar
  44. Oldstone, M. B. A., Aoki, T., and Dixon, F. J., 1972, The antibody response of mice to murine leukemia virus in spontaneous infection: Absence of classical immunologic tolerance, Proc. Natl. Acad. Sci. U.S.A. 69: 134.PubMedCrossRefGoogle Scholar
  45. Peters, R. L., Hartley, J. W., Spahn, G. J., Rabstein, L. S., Whitmire, C. E., Turner, H. C., and Huebner, R. J., 1972, Prevalence of the group-specific (gs) antigen and infectious virus expressions of murine C-type RNA viruses during the life span of BALB/cCR mice, Int. J. Cancer 10: 283.PubMedCrossRefGoogle Scholar
  46. Pincus, T., Hartley, J. W., and Rowe, W. P., 1971, A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occurring viruses, J. Exp. Med. 133: 1219.PubMedCrossRefGoogle Scholar
  47. Rowe, W. P., 1972, Studies of genetic transmission of murine leukemia virus by AKR mice. I. Crosses with Fv-1n strains of mice, J. Exp. Med. 136: 1272.PubMedCrossRefGoogle Scholar
  48. Rowe, W. P., and Pincus, T., 1972, Quantitative studies of naturally occurring murine leukemia virus infection of AKR mice, J. Exp. Med. 135: 429.PubMedCrossRefGoogle Scholar
  49. Rowe, W. P., Hartley, J. W., Lander, M. R., Pugh, W. E., and Teich, N., 1971, Noninfectious AKR mouse embryo cell lines in which each cell has the capacity to be activated to produce infectious murine leukemia virus, Virology 46: 866.PubMedCrossRefGoogle Scholar
  50. Schäfer, W., Hunsmann, G., Moennig, V., De Noronha, F., Bolognesi, D. P., Green, R. W., and Hiiper, G., 1975, Polypeptides of mammalian oncornaviruses II. Characterization of a murine leukemia virus polypeptide (p15) bearing interspecies reactivity, Virology 63: 48.CrossRefGoogle Scholar
  51. Schmidt, N. J., Lennette, E. H., and Dennis, J., 1968, Characterization of antibodies produced in natural and experimental coxsackie virus infections, J. Immunol 100: 99.PubMedGoogle Scholar
  52. Steeves, R. A., Strand, M., and August, J. T., 1974, Structural proteins of mammalian oncogenic RNA viruses: Murine leukemia virus neutralization of antisera prepared against purified envelope glycoprotein, J. Virol. 14: 187.PubMedGoogle Scholar
  53. Stephenson, J. R., Aaronson, S. A., Arnstein, P., Huebner, R. J., and Tronick, S. R., 1974, Demonstration of two immunologically distinct xenotropic type-C RNA viruses of mouse cells, Virology 61: 56.PubMedCrossRefGoogle Scholar
  54. Strand, M., Wilsnack, R., and August, J. T., 1974, Structural proteins of mammalian oncogenic RNA viruses: Immunological characterization of p15 polypeptide of Rauscher murine virus, J. Virol 14: 1575.PubMedGoogle Scholar
  55. Tennant, R. W., Schlufer, B., Yang, W. K., and Brown, A., 1974, Reciprocal inhibition of mouse leukemia virus infection by Fv-1 allele cell extracts, Proc. Natl Acad. Sci. U.S.A. 71: 4241.PubMedCrossRefGoogle Scholar
  56. Webster, R. G., 1968, The immune response to influenza virus. III. Changes in the avidity and specificity of early IgM and IgG antibodies, Immunology 14: 29.PubMedGoogle Scholar
  57. Witte, O. N., Weissman, I. L., and Kaplan, H. S., 1973, Structural characteristics of some murine RNA tumor viruses studied by lactoperoxidase iodination, Proc. Natl Acad. Sci. U.S.A. 70: 36.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1977

Authors and Affiliations

  • James N. Ihle
    • 1
  • M. G. HannaJr.
    • 1
  1. 1.Basic Research ProgramNCI Frederick Cancer Research CenterFrederickUSA

Personalised recommendations